Emcure Pharma IPO (Emcure Pharmaceuticals Limited IPO)

Emcure Pharma IPO Pulse

IPO Pulse Score of Emcure Pharma IPO is 61%

Interpretation of IPO Pulse Score

• Score above 80%: Strongly recommend to apply.
• Score between 60% to 80%: Moderately recommend, consider other qualitative factors.
• Score below 60%: Caution, recommend detailed analysis before applying.

Check IPO Pulse Score Past Performance

The IPO Pulse Score is a comprehensive measure designed to evaluate the attractiveness and potential of an Initial Public Offering (IPO). This score is derived from a detailed analysis of various key factors that are critical to the success of an IPO such as Revenue Growth, Profitability, Debt Levels, Return Ratios, Valuation Metrics, Market Share, Use of IPO Proceeds, Market Sentiment, Industry Growth, Competitive Advantage, Management Experience, Corporate Governance etc.

Disclaimer:

The IPO Pulse Score is intended solely for informational purposes. The score is derived from a combination of quantitative and qualitative factors that are subject to change. While we strive to provide accurate and up-to-date information, Investors are advised to conduct their own thorough research and consult with financial advisors before making any investment decisions. The IPO Pulse Score should not be the sole basis for any investment decision.

Emcure Pharma IPO Peers Comparison

Emcure Pharma IPO Comparison with Similar Listed Entities. Data as of 31st March 2024.

Name	Revenue(₹ Cr)	RoNW	P/E Ratio	PAT Margin
Emcure Pharmaceuticals Limited	6,658.2	16.87%		7.86
Dr. Reddy’s Laboratories Limited	28,011.1	19.74%	17.93	19.30
Cipla Limited	25,774	15.43%	30.10	15.66
Alkem Laboratories Limited	12,667.5	17.41%	33.86	13.96
Torrent Pharmaceuticals Limited	10,728	24.15%	57.74	15.35
Mankind Pharma Limited	10,334.7	20.43%	45.30	18.29
Abbott India Limited	5,848.9	32.48%	47.43	19.70
J. B. Chemicals & Pharmaceuticals Limited	3,484.1	18.90%	50.49	15.69